Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05222438
What this trial is testing

Trial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post Transplant

Who this might be right for
Relapsed Diffuse Large B-cell Lymphoma
Barbara Ann Karmanos Cancer Institute
Large-scale testing (Phase 3)Ended earlyNCT00651326
What this trial is testing

Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 48
Not applicableWithdrawnNCT04322084
What this trial is testing

Continuous Ambulatory Monitoring to Predict Elevated Risk of Infection in Children With Lymphoblastic Leukemia Undergoing Induction Chemotherapy (CAMPER-ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
St. Jude Children's Research Hospital
Early research (Phase 1)Study completedNCT02107235
What this trial is testing

Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer

Who this might be right for
Head and Neck NeoplasmsCarcinoma, Squamous Cell
Traws Pharma, Inc. 2
Not applicableStudy completedNCT01617278
What this trial is testing

I-Scan Versus High-definition White Light

Who this might be right for
Colorectal Cancer
University of Calgary 150
Not applicableUnknownNCT03681938
What this trial is testing

Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission?

Who this might be right for
Lymphoma, B-Cell
Institut Paoli-Calmettes 183
Testing effectiveness (Phase 2)Active Not RecruitingNCT03033914
What this trial is testing

A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)

Who this might be right for
Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center 82
Testing effectiveness (Phase 2)Ended earlyNCT01105702
What this trial is testing

Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma

Who this might be right for
Brain Cancer
NYU Langone Health 28
Not applicableActive Not RecruitingNCT05939128
What this trial is testing

A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA

Who this might be right for
Breast Cancer
AstraZeneca 625
Testing effectiveness (Phase 2)Looking for participantsNCT06992336
What this trial is testing

Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 411
Early research (Phase 1)Ended earlyNCT00963495
What this trial is testing

Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+4 more
University Health Network, Toronto 11
Testing effectiveness (Phase 2)Study completedNCT00847639
What this trial is testing

Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
Center for International Blood and Marrow Transplant Research 30
Testing effectiveness (Phase 2)Study completedNCT00165139
What this trial is testing

Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas

Who this might be right for
NeuroblastomaEwings SarcomaNon-rhabdomyosarcoma Soft Tissue Sarcoma
Dana-Farber Cancer Institute 20
Not applicableUnknownNCT03322072
What this trial is testing

Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating

Who this might be right for
Lung Cancer Stage ILung Cancer Stage IILung Cancer, Nonsmall Cell+2 more
CancerCare Manitoba 28
Post-approval studies (Phase 4)Active Not RecruitingNCT03975829
What this trial is testing

Pediatric Long-Term Follow-up and Rollover Study

Who this might be right for
Diffuse AstrocytomaAnaplastic AstrocytomaAstrocytoma+20 more
Novartis Pharmaceuticals 163
Not applicableStudy completedNCT01985828
What this trial is testing

CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Wake Forest University Health Sciences 83
Large-scale testing (Phase 3)Study completedNCT00053807
What this trial is testing

Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer

Who this might be right for
Kidney Cancer
European Organisation for Research and Treatment of Cancer - EORTC 96
Not applicableActive Not RecruitingNCT02177292
What this trial is testing

High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB)

Who this might be right for
Prostate Cancer
Medical College of Wisconsin 80
Large-scale testing (Phase 3)Active Not RecruitingNCT05933577
What this trial is testing

A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 1,089
Testing effectiveness (Phase 2)Looking for participantsNCT06134375
What this trial is testing

Tetrathiomolybdate (TM) Plus Capecitabine

Who this might be right for
Triple Negative Breast CancerResidual Disease
Dartmouth-Hitchcock Medical Center 204
Next Page